DiamPark is a neurotech specialized company targeting Parkinson's disease.
DiamPark has raised $356K in total funding. The most recent round was Seed. The last funding was announced in May 2023.
DiamPark's investors include Fast Forward Ventures.
DiamPark is headquartered in Chaville, France.
DiamPark is a neurotech specialized company targeting Parkinson's disease.
DiamPark is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DiamPark — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/diampark. Accessed September 16, 2026.
VCBacked. (2023). DiamPark — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/diampark
{{cite web |title=DiamPark — Funding & Investors |url=https://www.vcbacked.co/company/diampark |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated